Compile Data Set for Download or QSAR
maximum 50k data
Found 171 with Last Name = 'riedinger' and Initial = 'c'
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111568(US8618158, NCL-00016149)
Affinity DataIC50:  19nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111547(US8618158, NCL-00013774 | US8618158, NCL-00013775 ...)
Affinity DataIC50:  40nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50229787((4S,5R)-Nutlin-3 | (rac)-(4,5-bis(4-chlorophenyl)-...)
Affinity DataIC50:  61nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111569(US8618158, NCL-00016659)
Affinity DataIC50:  102nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111570(US8618158, NCL-00016653)
Affinity DataIC50:  102nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111547(US8618158, NCL-00013774 | US8618158, NCL-00013775 ...)
Affinity DataIC50:  143nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111532(US8618158, NU8399)
Affinity DataIC50:  152nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111540(US8618158, NCL-00010493)
Affinity DataIC50:  169nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339398((+)-R-3-(4-Chlorophenyl)-3-(1-hydroxymethylcyclopr...)
Affinity DataIC50:  170nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111539(US8618158, NCL-00010492)
Affinity DataIC50:  185nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339369((+/-)-3-(4-chlorophenyl)-3-((1-(hydroxymethyl)cycl...)
Affinity DataIC50:  230nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111546(US8618158, NU8405)
Affinity DataIC50:  274nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111542(US8618158, NCL-00010495)
Affinity DataIC50:  295nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111513(US8618158, NU8354)
Affinity DataIC50:  298nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111518(US8618158, NU8361)
Affinity DataIC50:  306nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339371((+/-)-trans-3-(4-Chlorophenyl)-3-(4-hydroxycyclohe...)
Affinity DataIC50:  310nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339355((+/-)-3-(4-Chlorophenyl)-3-(4-hydroxybutoxy)-2-(4-...)
Affinity DataIC50:  360nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111524(US8618158, NU8391)
Affinity DataIC50:  368nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111511(US8618158, NU8352)
Affinity DataIC50:  375nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339365((+/-)-trans-3-(4-Chlorophenyl)-3-(5-hydroxycyclooc...)
Affinity DataIC50:  380nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111517(US8618158, NU8360)
Affinity DataIC50:  388nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339370((+/-)-trans-3-(4-Chlorophenyl)-3-(4-hydroxycyclohe...)
Affinity DataIC50:  390nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111512(US8618158, NU8353)
Affinity DataIC50:  395nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339353((+/-)-(Z)-3-(4-Chlorophenyl)-3-(4-hydroxybut-2-eny...)
Affinity DataIC50:  400nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339437((+/-)-3-(4-chlorophenyl)-3-((cis)-3-hydroxycyclope...)
Affinity DataIC50:  400nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339368((+/-)-3-(4-Chlorophenyl)-3-(3-hydroxy-2,2-dimethyl...)
Affinity DataIC50:  400nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111509(US8618158, NU8350)
Affinity DataIC50:  402nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111510(US8618158, NU8351)
Affinity DataIC50:  405nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339354((+/-)-3-(4-Chlorophenyl)-3-(3-hydroxypropoxy)-2-(4...)
Affinity DataIC50:  450nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111545(US8618158, NU8401)
Affinity DataIC50:  492nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111554(US8618158, NU8398)
Affinity DataIC50:  510nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111531(US8618158, NU8398)
Affinity DataIC50:  510nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111516(US8618158, NU8359)
Affinity DataIC50:  569nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339361((+/-)-3-(4-Bromophenyl)-3-(4-hydroxybutoxy)-2-(4-n...)
Affinity DataIC50:  570nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339367((+/-)-cis-3-(4-Chlorophenyl)-3-(2-hydroxymethylcyc...)
Affinity DataIC50:  570nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111523(US8618158, NU8390)
Affinity DataIC50:  570nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339363((+/-)-trans-3-(4-Chlorophenyl)-3-(4-hydroxymethylc...)
Affinity DataIC50:  580nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111515(US8618158, NU8358)
Affinity DataIC50:  582nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111514(US8618158, NU8357)
Affinity DataIC50:  656nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339366((+/-)-3-(4-Chlorophenyl)-3-(4-hydroxybut-2-ynyloxy...)
Affinity DataIC50:  660nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111573(US8618158, NCL-00016895)
Affinity DataIC50:  680nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339436((+/-)-3-(4-Chlorophenyl)-3-(3-hydroxycyclopentoxy)...)
Affinity DataIC50:  700nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339364((+/-)-3-(4-Chlorophenyl)-3-(3-hydroxymethylbenzylo...)
Affinity DataIC50:  730nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111521(US8618158, NU8367)
Affinity DataIC50:  732nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111544(US8618158, NU8400)
Affinity DataIC50:  733nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111530(US8618158, NU8397)
Affinity DataIC50:  837nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111538(US8618158, NCL-00010490)
Affinity DataIC50:  847nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111543(US8618158, NCL-00010496)
Affinity DataIC50:  852nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM111519(US8618158, NU8365)
Affinity DataIC50:  869nMT: 2°CAssay Description:Streptavidin-coated 96-well plates are used to immobilise a biotin-tagged IP3 p53-derived peptide (MPRFMDYWEGLN). This is a peptide analogue derived ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Cancer Research Technology

US Patent
LigandPNGBDBM50339357((+/-)-(S)-3-(4-Chlorophenyl)-2-[1-(4-chlorophenyl)...)
Affinity DataIC50:  900nMAssay Description:Inhibition of Mdm2 -p53 protein interaction by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 171 total ) | Next | Last >>
Jump to: